Breaking News Instant updates and real-time market news.

ABB

ABB

$19.26

-0.155 (-0.80%)

, BERY

Berry Global

$50.13

-0.16 (-0.32%)

04:55
01/16/19
01/16
04:55
01/16/19
04:55

International Exposition Co will hold an expo

AHR Expo 2019 will be held in Atlanta, GA on January 14-16.

ABB

ABB

$19.26

-0.155 (-0.80%)

BERY

Berry Global

$50.13

-0.16 (-0.32%)

CC

Chemours

$32.67

-0.45 (-1.36%)

EMR

Emerson

$61.52

-0.16 (-0.26%)

FLIR

Flir Systems

$44.01

-0.38 (-0.86%)

HON

Honeywell

$137.77

0.15 (0.11%)

IOTS

Adesto Technologies

$5.09

-0.01 (-0.20%)

JCI

Johnson Controls

$31.70

-0.67 (-2.07%)

LII

Lennox

$224.50

0.625 (0.28%)

MSA

MSA Safety

$97.64

0.28 (0.29%)

PH

Parker-Hannifin

$154.36

-1.84 (-1.18%)

SPXC

SPX Corporation

$28.43

-0.6 (-2.07%)

TRMB

Trimble

$34.99

-0.38 (-1.07%)

UTX

United Technologies

$111.16

0.33 (0.30%)

WTS

Watts Water

$70.54

0.44 (0.63%)

  • 23

    Jan

  • 01

    Feb

  • 01

    Feb

  • 01

    Feb

  • 05

    Feb

  • 13

    Feb

  • 25

    Feb

  • 28

    Feb

  • 12

    Mar

  • 23

    May

ABB ABB
$19.26

-0.155 (-0.80%)

01/10/19
VERT
01/10/19
DOWNGRADE
Target $17
VERT
Sell
ABB downgraded to Sell from Hold at Vertical Research
Vertical Research analyst Jeffrey Sprague downgraded ABB to Sell and lowered his price target for the shares to $17 from $25. The analyst says that even before the recent drop in oil prices and mounting trade pressures on China he was concerned the company's backlog was insufficient to support its 2019 outlook.
01/08/19
BOFA
01/08/19
UPGRADE
BOFA
Buy
ABB upgraded to Buy from Neutral at BofA/Merrill
12/10/18
HSBC
12/10/18
UPGRADE
HSBC
Buy
ABB upgraded to Buy from Hold at HSBC
01/15/19
RBCM
01/15/19
INITIATION
RBCM
Sector Perform
ABB initiated with a Sector Perform at RBC Capital
BERY Berry Global
$50.13

-0.16 (-0.32%)

08/07/18
UBSW
08/07/18
DOWNGRADE
Target $54
UBSW
Neutral
Bemis downgraded to Neutral from Buy at UBS
UBS analyst Edlain Rodriguez downgraded Bemis (BMS) to Neutral following Amcor's offer to acquire the company. The analyst raised his price target for the shares to $54 from $52, which reflects a 50/50 blend of his standalone Bemis target of $52 and the implied current deal price of $55. Rodriguez says the closest plastic packaging peers to Bemis are Sealed Air (SEE), Berry Global (BERY) and Sonoco Products (SON).
08/15/18
RBCM
08/15/18
UPGRADE
Target $54
RBCM
Sector Perform
Bemis upgraded to Sector Perform at RBC Capital on expected Amcor deal approval
As reported earlier, RBC Capital analyst Arun Viswanathan upgraded Bemis to Sector Perform from Underperform and raised his price target to $54 from $44, saying that while he is cautious about the company's food packaging business, he expects the previously announced acquisition by Amcor to be approved by all parties with minimal divestitures. The analyst further states that the two companies are highly complementary and the combination should yield about $180M in synergies. Viswanathan also likes Berry Global (BERY) and Graphic Packaging Holding (GPK) based on their attractive valuation.
01/09/19
UBSW
01/09/19
NO CHANGE
Target $62
UBSW
Buy
Berry Global called a top pick for 2019 at UBS
UBS analyst Edlain Rodriguez raised his price target on Berry Global to $62 from $59 and called it a top pick for 2019. The analyst raised his estimates on the recent decline in resin costs and he expects consensus estimates to move higher. The analyst said key raw materials prices were major headwinds at the end of their fiscal year, but they tumbled in November and December. Rodriguez reiterated his Buy rating on Berry Global shares.
01/07/19
SBSH
01/07/19
UPGRADE
Target $27
SBSH
Buy
Silgan Holdings upgraded to Buy from Neutral at Citi
Citi analyst Anthony Pettinari upgraded Silgan Holdings (SLGN) to Buy with an unchanged price target of $27. The analyst says the upgrade reflects a more defensive positioning for Paper & Packaging in 2019. Following 2018's underperformance there are some supportive signs on valuation, with the Packagers' disconnect from Consumer Staples "especially noteworthy," Pettinari tells investors in a research note. Crown Holdings (CCK), Berry Global (BERY) and Graphic Packaging (GPK) are his top picks for 2019.
CC Chemours
$32.67

-0.45 (-1.36%)

01/08/19
01/08/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. VMware (VMW) resumed with a Buy at Citi. 2. CSX (CSX) and Kansas City Southern (KSU) were initiated with an Overweight at Atlantic Equities, while Union Pacific (UNP) was initiated with a Neutral. 3. First Solar (FSLR) and TerraForm Power (TERP) were initiated with an Overweight at Barclays, Covanta (CVA) and Azure Power (AZRE) were initiated with an Equal Weight, and SunPower (SPWR) was initiated with an Underweight. 4. At Home Group (HOME) initiated with a Buy at Monness Crespi. 5. Chemours (CC) initiated with a Buy at HSBC. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/04/19
SBSH
01/04/19
UPGRADE
Target $453
SBSH
Buy
Citi upgrades Sherwin-Williams to Buy on easing raw material costs
Citi analyst P.J. Juvekar upgraded Sherwin-Williams (SHW) to Buy from Neutral and raised his price target for the shares to $453 from $390. The analyst expects the company's raw material cost headwinds to ease and expects its "repair and remodel" business to remain strong. He also likes Air Products (APD) as a late-cycle play and upgraded Chemours (CC) this morning to Buy from Neutral.
01/04/19
SBSH
01/04/19
UPGRADE
Target $35
SBSH
Buy
Chemours upgraded to Buy from Neutral at Citi
Citi analyst P.J. Juvekar upgraded Chemours to Buy while lowering his price target for the shares to $35 from $38. "Trough" TiO2 conditions may be priced into the shares while Opteon adoption continues, Juvekar tells investors in a research note. The analyst remains selective on cyclical commodity companies.
01/08/19
HSBC
01/08/19
INITIATION
Target $16
HSBC
Buy
Chemours initiated with a Buy at HSBC
HSBC initiated Chemours with a Buy and $16 price target.
EMR Emerson
$61.52

-0.16 (-0.26%)

01/14/19
SBSH
01/14/19
UPGRADE
Target $66
SBSH
Neutral
Citi upgrades Emerson to Neutral on more balanced risk/reward
Citi analyst Andrew Kaplowtiz upgraded Emerson Electric to Neutral from Sell with a $66 price target. The analyst continues to expect slowing growth before larger project activity begins to contribute. However, he believes the recent pullback in the shares discounts this potential "air pocket" and views Emerson's risk/reward as more balanced at current levels.
01/14/19
01/14/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Snap (SNAP) upgraded to Neutral from Sell at Citi with analyst Mark May saying Snap is down 70% since February 2018 and its current valuation is below Twitter (TWTR) and Facebook's (FB) current and four-year average multiple. 2. Northrop Grumman (NOC) upgraded to Outperform from Neutral at Credit Suisse with analyst Robert Spingarn saying the market was not kind to Northrop Grumman in 2018, with the stock trading down about 21% for the year and about 32% off its high in April. 3. Alcoa (AA) and Teck Resources (TECK) were upgraded to Buy from Neutral at Goldman Sachs. 4. Sherwin-Williams (SHW) upgraded to Outperform from Market Perform at Wells Fargo with analyst Stephen East saying with the equity now trading at an 18.0 times PE multiple and the company growing 2019 EPS an estimated 17%-plus year over year, East believes investors appreciate the potential risks, but might not be appreciating the potential upside. 5. Emerson (EMR) upgraded to Neutral from Sell at Citi with analyst Andrew Kaplowtiz saying he continues to expect slowing growth before larger project activity begins to contribute. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/15/19
JPMS
01/15/19
NO CHANGE
JPMS
Neutral
GE risk/reward unfavorable into Q4 report, says JPMorgan's Tusa
JPMorgan analyst Stephen Tusa says the risk/reward on shares of General Electric (GE) is unfavorable into the company's Q4 earnings report. GE shares have bounced over the last month, outperforming the group by over 3,000 basis points, Tusa writes in a research note previewing earnings reports for the group. He believes the recent stock move "is built upon an expectation of more certainty in the path forward." Tusa thinks the focus on the earnings call should turn back to fundamentals, where he continues to see "disconnect with high level analyses from those who apparently ignore the mechanical headwinds from dilutive asset sales, a key aspect as to why FCF remains so weak." The call will "reinforce the Bear case that there is no concrete silver bullet plan, and much remains fluid, also negative," Tusa contends. He recommends Honeywell (HON) and Emerson Electric (EMR) as longs into the quarter and tells investors to avoid Johnson Controls (JCI), 3M (MMM) and Rockwell Automation (ROK). Tusa has a Neutral rating on General Electric.
01/14/19
SBSH
01/14/19
UPGRADE
SBSH
Neutral
Emerson upgraded to Neutral from Sell at Citi
FLIR Flir Systems
$44.01

-0.38 (-0.86%)

09/28/18
RHCO
09/28/18
NO CHANGE
Target $65
RHCO
Buy
Flir Systems facilities show operational improvements on track, says SunTrust
SunTrust analyst Michael Ciarmoli kept his Buy rating and $65 price target, saying his recent Santa Barbara facility tour and management meetings gave him more confidence that the company's operational improvements will yield continued margin expansion. The analyst further states that the detail around Flir's R&D spending and working capital management showcase its "totally revamped operating model", adding that the automotive opportunity from autonomous vehicle and advanced driver assistance represents a "free call option" on the stock.
08/20/18
08/20/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Nike (NKE) upgraded to Positive from Neutral at Susquehanna and to Overweight from Neutral at Piper Jaffray. 2. Qualcomm (QCOM) upgraded to Buy from Neutral at Rosenblatt with analyst Jun Zhang citing benefits from 5G smartphone growth over the next few years. 3. Flir Systems (FLIR) upgraded to Outperform from Market Perform at William Blair with analyst Louie DiPalma he believes, in the near-term, Flir's enhanced automation and software capabilities are rendering its sensors more powerful and driving adoption. Additionally, DiPalma believes thermal sensors will be common in autonomous vehicles over the longer term, which could be a major source of long-term upside. 4. RBS (RBS) upgraded to Buy from Neutral at Citi. 5. Terex (TEX) upgraded to Neutral from Underperform at Baird with analyst Mig Dobre citing its recent pullback and multiple compression as well as its upcoming investors day. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/01/18
IMPC
11/01/18
NO CHANGE
Target $51
IMPC
In-Line
Flir Systems price target lowered to $51 from $60 at Imperial Capital
Imperial Capital analyst Jeff Kessler lowered his price target for Flir Systems to $51 and keeps an In-Line rating on the shares following the company's Q3 results. He notes revenue and earnings missed expectations for the quarter. While Kessler is "very confident" in Flir's capabilities and technologies, at the current valuation of 13.8 times his 2019 EBITDA estimate, he prefers waiting for any combination of new Government project wins or acceleration of high-margin orders in the Industrial or Commercial segments before getting more constructive on the shares.
11/01/18
NEED
11/01/18
NO CHANGE
Target $60
NEED
Buy
Flir Systems price target lowered to $60 at Needham on lower organic growth
Needham analyst James Ricchiuti lowered his price target on Flir Systems to $60 from $62 to reflect the weaker than expected organic revenue growth of 3% reported in Q3. The analyst also keeps his Buy rating on the shares and recommends that investors take advantage of the 25% pullback in the stock price, citing the management's efforts to drive margins higher while pursuing new growth opportunities. Ricchiuti further points to the positives of Q3 that included better than expected operating margins and the highest operating cash flow for the quarter in 5 years.
HON Honeywell
$137.77

0.15 (0.11%)

01/08/19
OPCO
01/08/19
DOWNGRADE
OPCO
Perform
Honeywell downgraded to Perform from Outperform at Oppenheimer
01/08/19
01/08/19
DOWNGRADE

Perform
Honeywell downgraded to Perform at Oppenheimer
As previously reported, Oppenheimer analyst Christopher Glynn downgraded Honeywell to Perform from Outperform. The analyst notes that share price reduction includes impact of spins, modest multiple contraction, and higher than expected earnings dilution from spins. The market pullback notwithstanding, Glynn believes the thesis on Honeywell has played out. Additionally, in the context of fears of macro slowing, he would expect that the solid organic compounding at PMT and SPS over the past two years could emerge as comparison headwinds, notwithstanding some element of secular portfolio execution.
01/10/19
UBSW
01/10/19
NO CHANGE
Target $176
UBSW
Buy
Honeywell price target lowered to $176, remains top pick at UBS
UBS analyst Steven Winkler lowered his price target on Honeywell to $176 from $190 but said it remains a top pick for 2019 as he believes it is poised to meaningfully outperform its Industrial peers in 2019. The analyst believes Honeywell is now less cyclical, has higher growth potential, and is a more reliable cash generating business. Winkler reiterated his Buy rating on Honeywell shares.
IOTS Adesto Technologies
$5.09

-0.01 (-0.20%)

10/05/18
BNCH
10/05/18
NO CHANGE
Target $9
BNCH
Buy
Adesto weakness on memory pricing concerns a buying opportunity, says Benchmark
Benchmark analyst Gary Mobley attributes yesterday's weakness in shares of Adesto Technologies to a Digitimes article highlighting Nanya's Q3 revenue shortfall along with recent data points relating to weak DRAM and NAND flash pricing. However, he views yesterday price decline as an overreaction and reiterates his Buy rating on Adesto with a $9 price target.
11/01/18
RILY
11/01/18
NO CHANGE
Target $9.5
RILY
Buy
Adesto recent selloff brings buying opportunity, says B. Riley FBR
B. Riley FBR analyst Josh Nichols views Adesto Technologies as oversold and sees a "particularly attractive" buying opportunity ahead of the company's Q3 results in November 7. The analyst reiterates a Buy rating on the shares with a $9.50 price target.
09/19/18
ADAM
09/19/18
NO CHANGE
Target $9
ADAM
Buy
Adesto Technologies acquisition expands addressable market, says Canaccord
Canaccord analyst T. Michael Walkley said the acquisition of Echelon by Adesto Technologies expands its addressable market and it is anticipated more than half the synergies of the deal will be realized during Q4 2018. The analyst raised his estimates and he believes the company is uniquely positioned in the industrial IoT market with its products to generate strong long-term earnings growth. Walkley reiterated his Buy rating and $9 price target on Adesto Technologies shares.
07/30/18
COWN
07/30/18
INITIATION
Target $8
COWN
Outperform
Adesto Technologies initiated with an Outperform at Cowen
Cowen initiated Adesto Technologies with an Outperform and $8 price target.
JCI Johnson Controls
$31.70

-0.67 (-2.07%)

10/12/18
FBCO
10/12/18
INITIATION
FBCO
Outperform
EE, MI Sector initiated with Opportunistic View at Credit Suisse
Credit Suisse analyst John Walsh initiated the U.S. Electrical Equipment and Multi-Industry Sector with an Opportunistic View, telling investors in a research note that he believes at this point in the cycle stock appreciation will be driven by earnings growth and capital allocation. He is most positive on energy-related and non-residential end markets while cautious on Fossil Power markets. Specifically, Walsh initiated Allegion (ALLE), Eaton (ETN), Ingersoll-Rand (IR), Lennox (LII), 3M (MMM) and Xylem (XYL) with Outperform ratings, Acuity Brands (AYI), Emerson (EMR), Flowserve (FLS), Fortiv (FTV), GE (GE), Honeywell (HON) and Johnson Controls (JCI) with Neutral ratings and Rockwell Automation (ROK) with an Underperform rating.
11/16/18
FBCO
11/16/18
INITIATION
Target $54
FBCO
Outperform
Brookfield Business Partners reinstated with an Outperform at Credit Suisse
Credit Suisse analyst Andrew Kuske reinstated coverage of Brookfield Business Partners (BBU) with an Outperform rating and a $54 target price following a brief period of restriction associated with the $13.2B purchase of the Johnson Controls (JCI) Power Solutions Business unit. Given Brookfield's deployment of excess liquidity, Kuske tells investors in a research note that he views the transaction as being a positive for the stock and the deployment momentum that is also supported by strong private client fund raising.
11/14/18
OPCO
11/14/18
NO CHANGE
Target $39
OPCO
Outperform
Johnson Controls price target lowered to $39 from $44 at Oppenheimer
Oppenheimer analyst Noah Kaye lowered his price target for Johnson Controls (JCI) to $39 from $44 after the company announced an agreement to sell Power Solutions to Brookfield Business Partners (BBU), concluding the strategic review begun in March. The analyst believes the transaction multiple was reasonable, projected tax leakage was better than he had feared, and management was constructive on deploying sale proceeds for acquisitions. However, without accretive deal-making, the Power sale will be materially dilutive to Johnson Controls' earnings/free cash flow, even with buybacks and corporate savings, he contends. Kaye reiterates an Outperform rating on the shares.
LII Lennox
$224.50

0.625 (0.28%)

11/19/18
SPHN
11/19/18
INITIATION
Target $229
SPHN
Equal Weight
Lennox initiated with an Equal Weight at Stephens
Stephens analyst Rob McCarthy initiated Lennox with an Equal Weight rating and a price target of $229, saying the company's significant leverage to the North America HVAC market is "currently positive" but may become a headwind on "potentially slowing U.S. residential construction trends. The analyst states that Lennox's "solid premium product portfolio" and "seasoned management" are among its key strengths, but also believes that its shares are "close to fair value given substantial discounting of residential recovery".
12/10/18
BUCK
12/10/18
INITIATION
BUCK
Neutral
Lennox initiated with a Neutral at Buckingham
Buckingham analyst Robert Barry initiated Lennox with a Neutral rating and $219 price target. The analyst said that valuation looks fair outside heightened chatter of M&A, where he feels some deal scenarios are "logical, but quite speculative."
12/13/18
WBLR
12/13/18
NO CHANGE
WBLR
Outperform
Lennox called a top growth story for 2019 at William Blair
William Blair analyst Ryan Merkel calls Lennox International one of his firm's best growth stories for 2019. He views the company's analyst day as positive and keeps an Outperform rating on the name. The duration of Lennox's "high growth" is underappreciated by the Street and as the only HVAC pure-play, the stock deserves its premium valuation, Merkel tells investors in a research note. He keeps an Outperform rating on the name.
10/23/18
FBCO
10/23/18
NO CHANGE
Target $224
FBCO
Outperform
Lennox price target lowered to $224 from $229 at Credit Suisse
Credit Suisse analyst John Walsh lowered his price target for Lennox to $224 from $229 after a Q3 earnings miss driven by higher than expected tornado damages. The analyst notes that this is largely a timing issue as the company expects to fully recover the updated $1.25 of 2018 operational "core" lost profit and an additional 70c of lost earnings for 2019, next year. Walsh reiterates an Outperform rating on the shares.
MSA MSA Safety
$97.64

0.28 (0.29%)

01/10/19
WBLR
01/10/19
INITIATION
WBLR
Market Perform
MSA Safety initiated with a Market Perform at William Blair
William Blair analyst Lawrence De Maria started MSA Safety with a Market Perform rating.
12/21/18
BARD
12/21/18
DOWNGRADE
BARD
Neutral
MSA Safety downgraded to Neutral from Outperform at Baird
12/21/18
BARD
12/21/18
DOWNGRADE
Target $98
BARD
Neutral
MSA Safety downgraded to Neutral at Baird
As reported previously, Baird analyst Richard Eastman downgraded MSA Safety to Neutral from Outperform. The analyst sees a moderating sales/profit growth environment through calendar year 2020. He also cited risk to its elevated valuation given near-term sentiment indicators along with documented deceleration in key international economic regions, hawkish monetary policy, and trade protectionism, which are accelerating a recession sentiment. Eastman lowered his price target to $98 from $107 on MSA Safety shares.
12/21/18
12/21/18
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Facebook (FB) downgraded to Sell from Hold at DZ Bank. 2. TrueCar (TRUE) downgraded to Neutral from Buy at BTIG with analyst Marvin Fong saying factors outside of the company's control have "increased the degree of difficulty" for 2019. 3. Altria Group (MO) downgraded to Sell from Neutral at Citi with analyst Adam Spielman saying Altria's $12.8B investment for a 35% stake in Juul "is destroying value" but admits it is impossible to be sure because Altria has not revealed any financial details, "despite the scale of the investment." 4. Greif (GEF) downgraded to Market Perform from Outperform at Wells Fargo and to Underperform from Market Perform at BMO Capital. 5. Teradyne (TER) downgraded to Neutral from Outperform at Baird with analyst Richard Eastman saying he sees a moderating sales/profit growth environment through calendar year 2020. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
PH Parker-Hannifin
$154.36

-1.84 (-1.18%)

11/02/18
11/02/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Emergent BioSolutions (EBS) upgraded to Buy from Neutral at Goldman Sachs with analyst Dana Flanders saying he sees an "underappreciated opportunity" for Emergent to expand into other verticals, highlighted by Narcan nasal spray. 2. Michael Kors (KORS) upgraded to Buy from Neutral at UBS and to Overweight from Neutral at Piper Jaffray. 3. Parker-Hannifin (PH) upgraded to Outperform from Market Perform at Wells Fargo with analyst Andrew Casey sayoing the recent selloff has created an opportunity "to get back on board the PH stock train." 4. Ingredion (INGR) upgraded to Neutral from Sell at Citi with analyst David Driscoll saying the worst is now likely behind the company's North American operations, which should resume growth in 2019 "when many of the transitory 2018 issues will be in the rear view mirror." 5. VeriSign (VRSN) upgraded to Neutral from Underweight at JPMorgan and to Outperform from Neutral at Baird. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/15/18
COWN
10/15/18
DOWNGRADE
Target $150
COWN
Underperform
Parker-Hannifin downgraded to Underperform at Cowen
As reported previously, Cowen analyst Joseph Giordano downgraded Parker-Hannifin to Underperform from Market Perform. The analyst cited heightened geopolitical risks, evidence of moderating trends, and key macro indicators with seemingly little room to the upside, and waning estimate momentum. Giordano lowered his price target to $150 from $165 on Parker-Hannifin shares.
10/15/18
10/15/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Parker-Hannifin (PH) and Rockwell Automation (ROK) were downgraded to Underperform from Market Perform at Cowen. 2. Nutrisystem (NTRI) downgraded to Underperform from Neutral at DA Davidson with analyst Linda Bolton Weiser saying she is less confident in the company being able to achieve the over 30% growth in Q4 EBITDA implied by its guidance and believes that the management could cut its outlook, citing "anecdotal evidence" that "steep" price discounting of as high as 29% may be continuing for Nutrisystem's reactivation customers. 3. KLA-Tencor (KLAC) downgraded to In Line from Outperform at Evercore ISI with analyst CJ Muse saying his recent data suggest that WFE orders are tracking to fall about 10% to $45B in FY19, but the decline could be as high as 20% if memory spending does not recover from the DRAM inventory glut-driven slump. 4. Delphi Technologies (DLPH) downgraded to Equal Weight at Morgan Stanley with analyst Armintas Sinkevicius citing the "surprise" CEO transition, stating that the reasons for the change at the top are not clear. 5. Monster Beverage (MNST) downgraded to In Line from Outperform at Evercore ISI with analyst Robert Ottenstein saying he sees fitness/sports energy drinks being poised to take share from traditional energy drinks. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/02/18
WELS
11/02/18
UPGRADE
Target $193
WELS
Outperform
Parker-Hannifin upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Andrew Casey upgraded Parker-Hannifin to Outperform with an unchanged price target of $193. The recent selloff has created an opportunity "to get back on board the PH stock train," Casey tells investors in a research note. Beyond Parker-Hannifin's short-term earnings beat that was fueled by higher Aerospace segment margins, the analyst sees catalysts for further upside in the shares "despite persistent macro concerns about slowing growth." He expects North American and Aerospace demand continue to grow and points out the company is exiting a period of muted margin performance.
SPXC SPX Corporation
$28.43

-0.6 (-2.07%)

01/23/18
UBSW
01/23/18
INITIATION
Target $41
UBSW
Buy
SPX Corporation initiated with a Buy at UBS
UBS analyst Damian Karas initiated SPX Corporation with a Buy rating and $41 price target.
09/18/18
BUCK
09/18/18
INITIATION
Target $41
BUCK
Buy
SPX Corporation initiated with a Buy at Buckingham
Buckingham analyst Robert Barry initiated SPX Corporation with a Buy and $41 price target saying EBITDA growth will be driven by an improving organic top line, new products and supportive key end markets.
TRMB Trimble
$34.99

-0.38 (-1.07%)

01/10/19
JPMS
01/10/19
NO CHANGE
JPMS
JPMorgan changes ratings in Machinery ahead of Q4 earnings
JPMorgan analyst Ann Duignan says her U.S. Machinery coverage universe underperformed the broader market in 2018 as investors grew more concerned about the potential for a U.S. recession led by rising interest rates on top of a slowdown in international growth. As a result, the group looks "cheap" relative to the S&P 500 Index, Duignan tells investors in a research note. She also believes the selloff has been overdone for a number of stocks in her coverage. That said, the analyst thinks Eurozone growth is one of the biggest risks facing companies in space. As such, she suggests investors minimize exposure to companies with an outsized European Union mix. With this backdrop, Duignan upgraded both Oshkosh (OSK) and Trimble (TRMB) to Overweight from Neutral on valuation. She also downgraded Paccar (PCAR), Wabco (WBC) and Illinois Tool Works (ITW) to Underweight from Neutral given their exposure to Europe.
01/10/19
JPMS
01/10/19
UPGRADE
Target $40
JPMS
Overweight
Trimble upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Ann Duignan upgraded Trimble to Overweight while lowering her price target for the shares to $40 from $41.
06/06/18
06/06/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Yelp (YELP) downgraded to Sector Weight from Overweight at KeyBanc analyst Brad Erickson saying his latest customer checks, combined with updated views of Request a Quote, diminish his prior views for upside potential in the name. 2. Macy's (M) downgraded to Neutral from Overweight at Atlantic Equities while Kohl's (KSS) was downgraded to Underweight from Neutral. 3. BHP Billiton (BHP) and BHP Billiton plc (BBL) were downgraded to Neutral from Buy at BofA/Merrill. 4. Trimble (TRMB) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Jerry Revich saying while he is still bullish on the long-term outlook for rising adoption rates of Trimble's core productivity-enhancing software and hardware, he views the company's key end-markets as more balanced now. 5. Ambarella (AMBA) downgraded to Perform from Outperform at Oppenheimer with analyst Andrew Uerkwitz citing the company's Q1 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/02/18
BREN
08/02/18
NO CHANGE
Target $48
BREN
Buy
Trimble Q2 beat on all metrics, says Berenberg
Berenberg analyst Gal Munda raised his price target for Trimble to $48 from $46 saying the company's Q2 results beat on all metrics. The analyst cites the beat, improved end market exposure and accelerating growth for his increased price target and keeps a Buy rating on the shares.
UTX United Technologies
$111.16

0.33 (0.30%)

12/11/18
MSCO
12/11/18
NO CHANGE
MSCO
Morgan Stanley sees further room for Defense stocks to advance
Morgan Stanley analyst Rajeev Lalwani said he is constructive on Defense stocks following yesterday's 4% move up, noting that budgets now appear to be on a better track and point to growth again. Defense stocks have recently performed poorly, consistent with other Industrial sectors, he points out, adding that he thinks the sector should do well in a period of economic uncertainty. In terms of individual names, Lalwani said his preference remains Raytheon (RTN) and Lockheed Martin (LMT), on which he has Overweight ratings. He maintains an Underweight rating on General Dynamics (GD). Other publicly traded companies in the Defense space include BAE Systems (BAESY), Boeing (BA), Northrop Grumman (NOC), and United Technologies (UTX).
01/03/19
RBCM
01/03/19
DOWNGRADE
Target $119
RBCM
Sector Perform
United Technologies downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital analyst Deane Dray downgraded United Technologies to Sector Perform from Outperform and lowered his price target to $119 from $139.
01/03/19
SBSH
01/03/19
INITIATION
Target $120
SBSH
Neutral
United Technologies resumed with a Neutral at Citi
Citi analyst Jonathan Raviv resumed coverage of United Technologies with a Neutral rating and lowered his price target for the shares to $120 from $125. The biggest catalyst came in late November when the company announced the closure of the Rockwell Collins acquisition and the planned three-way split between Aero, Otis and Carrier, Raviv tells investors in a research note. The analyst says the next big catalyst isn't for another 18-24 months when the split becomes official.
01/04/19
RBCM
01/04/19
DOWNGRADE
Target $119
RBCM
Sector Perform
United Technologies downgraded to Sector Perform from Outperform at RBC Capital
As noted earlier, RBC Capital analyst Deane Dray downgraded United Technologies to Sector Perform from Outperform and lowered his price target to $119 from $139. The analyst believes that shares are likely "stuck in limbo" until the mid-late 2020 spin transactions, adding that the potential upside from the possible Carrier is not enough to keep him positive. Dray further warns about the "potential for some spin-related business disruptions and market share losses during this limbo period."
WTS Watts Water
$70.54

0.44 (0.63%)

12/04/18
GHSC
12/04/18
UPGRADE
Target $90
GHSC
Buy
Watts Water upgraded to Buy from Neutral at Seaport Global
Seaport Global analyst Walt Liptak upgraded Watts Water to Buy from Neutral and raised its price target to $90 from $83. Liptak said the selloff in shares provides a buying opportunity ahead of 2019 market share gains and profitability driven by sector growth, new products, and European restructuring. The analyst expects Watts' new product strategy that has already resulted in an acceleration in the Americas organic sales growth rate to continue into 2019 and for price increases and internal profit improvement initiatives to support earnings.
02/14/18
JANY
02/14/18
UPGRADE
JANY
Buy
Watts Water upgraded to Buy from Neutral at Janney Capital
02/14/18
02/14/18
UPGRADE
Target $83

Buy
Watts Water upgraded to Buy on lower taxes, higher multiple at Janney Capital
As previously reported, Janney Capital analyst Michael Gaugler upgraded Watts Water to Buy from Neutral after he raised his 2018 and 2019 estimates based on lowered income tax assumptions and raised his P/E multiple for the stock to 21x from 20x. Gaugler increased his fair value estimate on Watts shares to $83 from $69.
03/21/18
BOSC
03/21/18
DOWNGRADE
BOSC
Neutral
Watts Water downgraded to Neutral from Outperform at Boenning & Scattergood
Boenning & Scattergood downgraded Watts Water to Neutral from Outperform citing valuation.

TODAY'S FREE FLY STORIES

LION

Fidelity Southern

$28.41

-0.16 (-0.56%)

12:48
01/17/19
01/17
12:48
01/17/19
12:48
Earnings
Fidelity Southern reports Q4 EPS 36c, consensus 33c »

Total assets decreased by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$49.50

0.37 (0.75%)

12:45
01/17/19
01/17
12:45
01/17/19
12:45
Options
Bristol Myers Squibb call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 28

    Jan

  • 28

    Feb

  • 18

    May

  • 20

    May

12:45
01/17/19
01/17
12:45
01/17/19
12:45
General news
Treasury's $13 B 10-year TIPS preview: the auction may suffer »

Treasury's $13 B…

FOSL

Fossil

$17.50

0.09 (0.52%)

, GOOG

Alphabet

$1,080.85

0.63 (0.06%)

12:44
01/17/19
01/17
12:44
01/17/19
12:44
Hot Stocks
Breaking Hot Stocks news story on Fossil, Alphabet, Alphabet Class A »

Fossil jumps 7.6% after…

FOSL

Fossil

$17.50

0.09 (0.52%)

GOOG

Alphabet

$1,080.85

0.63 (0.06%)

GOOGL

Alphabet Class A

$1,090.00

1.17 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 04

    Feb

  • 04

    Feb

  • 25

    Feb

  • 03

    Mar

RTN

Raytheon

$161.77

2.4 (1.51%)

12:32
01/17/19
01/17
12:32
01/17/19
12:32
Hot Stocks
Raytheon awarded $434M contract modification for SPY-6 AIM-9X tactical missiles »

Raytheon Company was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,079.92

-0.3 (-0.03%)

, FOSL

Fossil

$17.50

0.09 (0.52%)

12:31
01/17/19
01/17
12:31
01/17/19
12:31
Hot Stocks
Fossil to sell select smartwatch technology to Google for $40M »

Fossil Group (FOSL)…

GOOG

Alphabet

$1,079.92

-0.3 (-0.03%)

FOSL

Fossil

$17.50

0.09 (0.52%)

GOOGL

Alphabet Class A

$1,089.70

0.87 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 04

    Feb

  • 04

    Feb

  • 25

    Feb

  • 03

    Mar

JPM

JPMorgan

$102.54

0.06 (0.06%)

12:30
01/17/19
01/17
12:30
01/17/19
12:30
Options
Call butterfly in JP Morgan is similar to one in Wells Fargo »

Call butterfly in JP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

PHG

Philips

$35.40

(0.00%)

12:29
01/17/19
01/17
12:29
01/17/19
12:29
Periodicals
Philips to shutter U.K. factory as Brexit concerns intensify, Bloomberg says »

Royal Philips intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMFA

LM Funding

$2.19

0.765 (53.87%)

12:27
01/17/19
01/17
12:27
01/17/19
12:27
Hot Stocks
LM Funding spikes 53% after completing IIU acquisition, sees accretion in 2019 »

Earlier on Thursday, LM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NWSA

News Corp.

$12.42

0.03 (0.24%)

12:25
01/17/19
01/17
12:25
01/17/19
12:25
Upgrade
News Corp. rating change  »

News Corp. upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDC

First Data

$22.17

0.9 (4.23%)

12:25
01/17/19
01/17
12:25
01/17/19
12:25
Options
First Data call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

BLK

BlackRock

$410.20

-2.65 (-0.64%)

12:25
01/17/19
01/17
12:25
01/17/19
12:25
Periodicals
BlackRock CEO calls on business leaders to tackle social issues, FT says »

BlackRock CEO Larry Fink…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 29

    Jan

  • 11

    Feb

MS

Morgan Stanley

$42.66

-1.82 (-4.09%)

, AAPL

Apple

$154.13

-0.75 (-0.48%)

12:22
01/17/19
01/17
12:22
01/17/19
12:22
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks opened in negative…

MS

Morgan Stanley

$42.66

-1.82 (-4.09%)

AAPL

Apple

$154.13

-0.75 (-0.48%)

JNJ

Johnson & Johnson

$128.65

0.65 (0.51%)

SHLD

Sears

$0.00

(0.00%)

SBNY

Signature Bank

$120.40

7.98 (7.10%)

MTB

M&T Bank

$161.77

7.32 (4.74%)

SIG

Signet Jewelers

$25.63

-7.745 (-23.21%)

WDC

Western Digital

$35.97

-1.83 (-4.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 22

    Jan

  • 24

    Jan

  • 27

    Jan

  • 29

    Jan

  • 07

    Feb

  • 18

    Feb

LPCN

Lipocine

$2.24

0.65 (40.88%)

12:17
01/17/19
01/17
12:17
01/17/19
12:17
Recommendations
Lipocine analyst commentary  »

Ladenburg reiterates Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
01/17/19
01/17
12:17
01/17/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMB

Limbach Holding

$5.00

(0.00%)

12:16
01/17/19
01/17
12:16
01/17/19
12:16
Hot Stocks
Limbach awarded contracts totaling $81.4M for hospital construction »

Limbach Holdings provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
01/17/19
01/17
12:16
01/17/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPCN

Lipocine

$2.27

0.68 (42.77%)

12:12
01/17/19
01/17
12:12
01/17/19
12:12
Periodicals
Lipocine NASH data contain plenty of 'red flags,' STAT's Feuerstein writes »

This morning's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVE

Cenovus Energy

$7.79

-0.19 (-2.38%)

12:10
01/17/19
01/17
12:10
01/17/19
12:10
Options
Second day of call buying in Cenovus Energy continues as shares slump »

Second day of call buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SQ

Square

$68.79

2.9 (4.40%)

12:04
01/17/19
01/17
12:04
01/17/19
12:04
Hot Stocks
Square launches free debit card for business, with sellers access to funds »

Square announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 03

    Mar

ALBO

Albireo Pharma

$24.54

0.08 (0.33%)

12:03
01/17/19
01/17
12:03
01/17/19
12:03
Hot Stocks
Albireo Pharma treatment of biliary atresia granted FDA orphan status »

Albireo Pharma's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPOR

Gulfport Energy

$8.67

-0.23 (-2.58%)

12:02
01/17/19
01/17
12:02
01/17/19
12:02
Hot Stocks
Gulfport Energy confirms receipt of Firefly letter »

Gulfport Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNFI

United Natural Foods

$13.09

-2.32 (-15.06%)

12:00
01/17/19
01/17
12:00
01/17/19
12:00
Hot Stocks
United Natural Foods falls -15.1% »

United Natural Foods is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESTE

Earthstone Energy

$5.28

-1.49 (-22.01%)

12:00
01/17/19
01/17
12:00
01/17/19
12:00
Hot Stocks
Earthstone Energy falls -21.9% »

Earthstone Energy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIG

Signet Jewelers

$25.49

-7.885 (-23.63%)

12:00
01/17/19
01/17
12:00
01/17/19
12:00
Hot Stocks
Signet Jewelers falls -23.6% »

Signet Jewelers is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.